VF
LXEO icon

Virtu Financial’s Lexeo Therapeutics LXEO Stock Holding History

Virtu Financial’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68K Buy
+11,901
New +$84.3K ﹤0.01% 1240
2025
Q4 		– Sell
-43,269
Closed -$287K – 1987
2025
Q3 		$287K Buy
+43,269
New +$209K 0.02% 758

Other funds holding LXEO

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial's LXEO Position: Q1 2026 in Review

Virtu Financial opened a new position in Lexeo Therapeutics (LXEO) in Q1 2026: 11,901 shares worth $68K. The stake represents ﹤0.01% of the portfolio and ranks #1240 among its holdings. This is a return to the name: Virtu Financial previously reported a position in LXEO as recently as Q3 2025.

Virtu Financial first reported a position in LXEO in Q3 2025 and has held it in 2 quarters since. The position peaked at $287K in Q3 2025. 139 funds tracked by Wall St. Rank hold LXEO as of Q1 2026.

  • Virtu Financial held 11,901 shares of Lexeo Therapeutics worth $68K as of Q1 2026.
  • Lexeo Therapeutics was a new Virtu Financial position in Q1 2026.
  • Lexeo Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1240 holding.
  • Virtu Financial first reported a position in Lexeo Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • Virtu Financial's Lexeo Therapeutics position peaked at $287K in Q3 2025.
  • 139 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.